News &
Publications

Contacts

Lisa Bailey
Interim Director of Communications
Director of Social Networking
215-214-3954
215-872-5846 (cell phone)
Lisa.Bailey@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

HHS Names Fox Chase Cancer Center Nurse Practitioner to Secretary's Advisory Committee; Secretary Tommy Thompson Taps Agnes Masny for Committee on Genetics, Health and Society

PHILADELPHIA (December 24, 2002) -- The U.S. Department of Health and Human Services Secretary Tommy G. Thompson has selected Fox Chase Cancer Center's Agnes Masny RN, MPH, MSN, CRNP, to join the Secretary's Advisory Committee on Genetics, Health and Society.

Masny, of Roslyn, Pa., a nurse practitioner and genetics educator with Fox Chase Cancer Center's Margaret Dyson Family Risk Assessment Program, will be joined by 12 physicians, scientists and other experts on the newly appointed committee. The committee's new charge is an expansion of the mission of the Secretary's Advisory Committee on Genetic Testing to broadly consider the impact of genetic technologies on society.

"This committee's members bring strong scientific, professional and personal backgrounds and an understanding of the serious health and ethical issues raised by new genetic technologies," Secretary Thompson said. "...They will provide sound and thoughtful advice to the department as we weigh the impact of these advances on the health and welfare of all Americans."

At the department's request, the committee may consider the broad range of human health and societal issues involving the development, use and potential misuse of genetic technologies and make recommendations as appropriate. The committee's charge includes considering the clinical, ethical, legal and societal implications of genetic testing and other technologies, and its members include experts in each of those areas, as well as consumer representatives.

In addition to Masny, the newly named committee members are:

  • Edward McCabe, M.D., Ph.D., committee chair, and executive chair of the pediatrics department at the University of California-Los Angeles and physician-in-chief at UCLA's Mattel Children's Hospital.
  • Cynthia E. Berry, J.D., of Great Falls, Va., the general counsel and managing director for Wexler and Walker Public Policy Associates.
  • Barbara Willis Harrison, M.S., of Washington, D.C., a genetic counselor and instructor both in pediatrics and in health care ethics at Howard University College of Medicine.
  • C. Christopher Hook, M.D., of Rochester, Minn., the director of ethics education at the Mayo Graduate School of Medicine and an assistant professor at the Mayo Medical Clinic.
  • Eric S. Lander, Ph.D., of Cambridge, Mass., director of the Whitehead Institute for Genome Research and a professor of biology at the Massachusetts Institute of Technology.
  • Debra G.B. Leonard, M.D., Ph.D., of Philadelphia, Pa., an assistant professor of pathology and director of the Molecular Pathology Laboratory at the Hospital of the University of Pennsylvania.
  • Brad Margus, of Boca Raton, Fla., co-founder and volunteer president of the A-T Children's Project, which raises funds for research into a lethal childhood genetic neurogenerative disease called ataxia telangiectasia.
  • Joan Reede, M.D., M.P.H., M.S., of Cambridge, Mass., an assistant professor of maternal and child health at the Harvard School of Public Health and an assistant professor of medicine at the Harvard Medical School.
  • Reed V. Tuckson, M.D., of Minneapolis, Minn., senior vice president of consumer health and medical care advancement at UnitedHealth Group.
  • Huntington F. Willard, Ph.D., the incoming director of the Institute for Genome Sciences and Policy and Vice Chancellor for Genome Sciences at Duke University in Durham, N.C.
  • Emily S. Winn-Deen, Ph.D., of Pleasanton, Calif., the senior director for genomics business for Roche Molecular Systems.
  • Kimberly S. Zellmer, J.D., of Mission Hills, Kan., an attorney and mother to a child with Batten's Disease.

Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Media inquiries only, please contact Diana Quattrone at 215-728-7784.

More 2002 News Releases »